Method of administering liposomal encapsulated taxane
US6146659A · kind A · utility
26Cited by
4References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 1, 1998 |
| Grant date | Nov 14, 2000 |
| Priority date | — |
| Expiry date | Jul 1, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Liposomal-encapsulated taxane or an antineoplastic derivative thereof or a mixture thereof is provided which is used to effect a therapeutically enhanced method of treating cancer. The liposomal encapsulated paclitaxel allows for administration to a patient in less than one hour.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.